Use of Surrogate Measures in Cost-Effectiveness Analyses of Lipid-Lowering Therapies

Scandinavian Simvastatin Survival Study Group, 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study, Lancet, 344, 1383 Shepherd, 1995, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia, N Engl J Med, 333, 1301, 10.1056/NEJM199511163332001 Caro, 1997, The West of Scotland Coronary Prevention Study: economic benefit analysis of primary prevention with pravastatin, Br Med J, 315, 1577, 10.1136/bmj.315.7122.1577 Johannesson, 1997, Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease, N Engl J Med, 336, 332, 10.1056/NEJM199701303360503 Lipid Research Clinics Program, 1984, The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA, 25l, 365 Gould, 1995, Cholesterol reduction yields clinical benefit. A new look at old data, Circulation, 91, 2274, 10.1161/01.CIR.91.8.2274 Hebert, 1997, Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials, JAMA, 278, 313, 10.1001/jama.1997.03550040069040 Shepherd, 1998, Prevention of heart disease: is LDL reduction the outcome of choice? No, there is more, Value Health, 1, 120, 10.1046/j.1524-4733.1998.120120.x Schulman, 1990, Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management, JAMA, 264, 3025, 10.1001/jama.1990.03450230061030 Delea TE, Hogan TJ, Gasper MC, McGarry LJ, Oster G. Cost-effectiveness of cholesterol lowering drugs: a re-examination of treatment alternatives. Unpublished manuscript. Coronary Drug Project Research Group, 1975, Clofibrate and niacin in coronary heart disease, JAMA, 231, 360, 10.1001/jama.1975.03240160024021 Coronary Drug Project Research Group, 1972, The Coronary Drug Project: findings leading to further modifications of its protocol with respect to dextrothyroxine, JAMA, 220, 996, 10.1001/jama.1972.03200070084015 Lipid Research Clinics Program, 1984, The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease, JAMA, 251, 351, 10.1001/jama.1984.03340270029025 Research Committee of the Scottish Society of Physicians, 1971, Ischaemic heart disease: a secondary prevention trial using clofibrate, Br Med J, 4, 775, 10.1136/bmj.4.5790.775 Dayton, 1969, A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis, Circulation, 40, 1 Research Committee to the Medical Research Council, 1965, Low-fat diet in myocardial infarction—a controlled trial, Lancet, 2, 501, 10.1016/S0140-6736(65)91469-8 Research Committee to the Medical Research Council, 1968, Controlled trial of soya-bean oil in myocardial infarction, Lancet, 2, 693 Group of Physicians of the Newcastle Upon Tyne Region, 1971, Trial of clofibrate in the treatment of is-chaemic heart disease, Br Med J, 4, 767 Leren, 1970, The Oslo Diet Heart Study: eleven-year report, Circulation, 42, 935, 10.1161/01.CIR.42.5.935 Committee of Principal Investigators, 1978, WHO Clofibrate Trial: a cooperative trial in the primary prevention of ischaemic heart disease using clofibrate, Br Heart J, 40, 1069, 10.1136/hrt.40.10.1069